11:19 AM EST, 11/17/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were slightly lower late Monday morning, edging 0.1% lower to 1,610.86 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and pharmaceutical company Ascendis Pharma ( ASND ) , which climbed 7.5% and 7.2%, respectively. They were followed by biopharmaceutical companies DBV Technologies ( DBVT ) and Genfit ( GNFT ) , which advanced 5.4% and 3.5%, respectively.

The decliners from continental Europe were led by software firm SAP (SAP) and lender Banco Santander (SAN), which fell 1.9% each. They were followed by brewing company Anheuser-Busch InBev ( BUD ) and health technology company Philips (PHG), which were down 1.6% and 1.4%, respectively.

From the UK and Ireland, the gainers were led by communications company WPP ( WPP ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which rose 11% and 2.5%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and pharmaceutical company GSK (GSK), which were up 2.3% and 0.9%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which dropped 6.6% and 3.8%, respectively. They were followed by biopharmaceutical companies Akari Therapeutics ( AKTX ) and NuCana ( NCNA ) , which lost 3.4% and 2.6%, respectively.